Medcell Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 0.10 M
- Company Age 2 Year, 4 Months
- Open Charges ₹ 10.00 Cr
About Medcell Pharma
Medcell Pharma Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 September 2022 (Two years and four months 20 days old ). Its registered office is in Gurugram, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹10.00 Cr.
Aditya Bhatia, Anita Bhatia, and Gunjan Bhatia serve as directors at the Company.
Company Details
- Location
Gurugram, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230HR2022PTC106564
- Company No.
106564
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Sep 2022
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Medcell Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aditya Bhatia  | Director | 13-Sep-2022 | Current |
| Anita Bhatia | Director | 01-Sep-2023 | Current |
| Gunjan Bhatia | Director | 13-Sep-2022 | Current |
Financial Performance of Medcell Pharma.
Enhance accessibility to Medcell Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Medcell Pharma?
Unlock access to Medcell Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Ruxall Vita Private LimitedAditya Bhatia, Anita Bhatia and 1 more are mutual person
- Zypher Lifesciences Private Limited
Aditya Bhatia, Anita Bhatia and 1 more are mutual person
Charges (Loans)
₹10.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 10.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Feb 2024 | Hdfc Bank Limited | ₹10.00 Cr | Open |
How Many Employees Work at Medcell Pharma?
Medcell Pharma has a workforce of 133 employees as of Jul 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medcell Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medcell Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.